0000904454-17-000019.txt : 20170109 0000904454-17-000019.hdr.sgml : 20170109 20170109130459 ACCESSION NUMBER: 0000904454-17-000019 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20170109 DATE AS OF CHANGE: 20170109 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: CoLucid Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001348649 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 203419541 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-88836 FILM NUMBER: 17516718 BUSINESS ADDRESS: STREET 1: 222 THIRD STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 781-365-2596 MAIL ADDRESS: STREET 1: 222 THIRD STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Colucid Pharmaceuticals Inc DATE OF NAME CHANGE: 20060104 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Domain Partners VI, L.P. CENTRAL INDEX KEY: 0001298033 IRS NUMBER: 331073839 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: ONE PALMER SQUARE CITY: PRINCETON STATE: NJ ZIP: 08542 BUSINESS PHONE: (609) 683-5656 MAIL ADDRESS: STREET 1: ONE PALMER SQUARE CITY: PRINCETON STATE: NJ ZIP: 08542 SC 13G/A 1 13ga_010717-colucid.htm SCHEDULE 13G/A FOR COLUCID PHARMACEUTICALS, INC. BY DOMAIN PARTNERS VI, L.P.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
_____________________

SCHEDULE 13G
(Rule 13d-102)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1(b),(c) AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2(b)
(Amendment No. 1)1

CoLucid Pharmaceuticals, Inc.
(Name of Issuer)
 
Common Stock, $0.001 par value
(Title of Class of Securities)
 
19716T101
(CUSIP Number)
 
December 31, 2016
Date of Event Which Requires Filing of this Statement


Check the appropriate box to designate the rule pursuant to which this Schedule is Filed:

[   ] Rule 13d-1(b)
[   ] Rule 13d-1(c)
[X] Rule 13d-1(d)


_______________________

1The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.  The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act.
 
 
 
 
 
 
 
CUSIP No. 19716T101
 
 
1)
Name of Reporting Person
I.R.S. Identification No. of Above Person (Entities Only) (Voluntary)
 
Domain Partners VI, L.P.
2)
Check the Appropriate Box if a Member of a Group
 
 
(a)  [X]
(b)  [   ]
3)
SEC Use Only
 
 
  
4)
Citizenship or Place of Organization
 
Delaware
 
Number of
Shares Beneficially
Owned by Each
Reporting Person
With
 
5)
Sole Voting Power
-0-
6)
Shared Voting Power
-0-
7)
Sole Dispositive Power
-0-
8)
Shared Dispositive Power
-0-
9)
Aggregate Amount Beneficially Owned by Each Reporting Person
 
-0-
10)
Check if the Aggregate Amount in Row (9) Excludes Certain Shares
 
[   ]
11)
Percent of Class Represented by Amount in Row (9)
 
0%
12)
Type of Reporting Person
 
PN

 
 
 
 
2

CUSIP No. 19716T101

 
1)
Name of Reporting Person
I.R.S. Identification No. of Above Person (Entities Only) (Voluntary)
 
DP VI Associates, L.P.
2)
Check the Appropriate Box if a Member of a Group
 
 
(a)  [X]
(b)  [   ]
3)
SEC Use Only
 
 
  
4)
Citizenship or Place of Organization
 
Delaware
 
Number of
Shares Beneficially
Owned by Each
Reporting Person
With
 
5)
Sole Voting Power
-0-
6)
Shared Voting Power
-0-
7)
Sole Dispositive Power
-0-
8)
Shared Dispositive Power
-0-
9)
Aggregate Amount Beneficially Owned by Each Reporting Person
 
-0-
10)
Check if the Aggregate Amount in Row (9) Excludes Certain Shares
 
[   ]
11)
Percent of Class Represented by Amount in Row (9)
 
0%
12)
Type of Reporting Person
 
PN
 
 
 

 
3
 
CUSIP No. 19716T101
 
 
Amendment No. 1 to Schedule 13G (Final Amendment)

Reference is hereby made to the statement on Schedule 13G filed with the Securities and Exchange Commission on behalf of the Reporting Persons with respect to the Common Stock of the Issuer on January 19, 2016 (the "Schedule 13G").  Terms defined in the Schedule 13G are used herein as so defined.

The following items of the Schedule 13G are hereby amended and restated as follows:
 
Item 4
–
Ownership.
     
(a) through (c):
     
The information set forth in Items 5 through 9 and 11 of the cover pages to this Amendment No. 1 to Schedule 13G is incorporated herein by reference.  The ownership reported therein is as of December 31, 2016.
     
Item 5
–
Ownership of Five Percent or Less of a Class:
   
If this statement is being filed to report the fact that the Reporting Persons have ceased to be the beneficial owners of more than five percent of the Common Stock, check the following:  [X]

 
4

CUSIP No. 19716T101
 
 
Signature

After reasonable inquiry and to the best of their knowledge and belief, the undersigned hereby certify that the information set forth in this statement is true, complete and correct.

Dated:  January 9, 2017

 
DOMAIN PARTNERS VI, L.P.
 
  
 
By:
One Palmer Square Associates VI, L.L.C., General Partner
 
  
 
By:
/s/ Lisa A. Kraeutler
  
   
Attorney-in-Fact
 
 
  
 
DP VI ASSOCIATES, L.P.
 
  
 
By:
One Palmer Square Associates VI, L.L.C., General Partner
 
  
 
By:
/s/ Lisa A. Kraeutler
  
   
Attorney-in-Fact
 
 
  

 
 
 
 
5